brochure

What’s New

PIPELINE

Brochure : MEPS-X series

Brochure
More
Brochure
More

TECHNOLOGY

Innovative platforms for drug development

HUMAN ORGAN MODEL CHIP
HUMAN ORGAN-ON-A-CHIP
BIOMIMETIC NANOPARTICLE
BIOMIMETIC NANOPARTICLE
NANOPARTICLE MANUFACTURING
NANOPARTICLE
MANUFACTURING
MG-X series
MEPS-X series

PIPELINE

MG-X series

Lipid nanoparticle drug delivery system mass produced by microfluidic mixing technology

MEPS-X series

3D multi-structure tissue chip platform manufactured by high-precision injection molding process

MORE

MEDIA

[BIO USA 2023] Korea Biotech Partnership _ Strength and Potential of K-biotech
[BIO USA 2023] Korea Biotech Partnership _ Strength and Potential of K-biotech
2023.06.02
MEPSGEN Launches LNP Production Platform...Details Are Unveiled at BIO Conventional
MEPSGEN Launches LNP Production Platform...Details Are Unveiled at BIO Conventional
2023.06.02
MEPSGEN signs MOU with CELLARTGEN
MEPSGEN signs MOU with CELLARTGEN
2023.05.25
MEPSGEN signs MOU with CorestemChemon
MEPSGEN signs MOU with CorestemChemon
2023.05.19
MEPSGEN signs MOU with Woojung Bio
MEPSGEN signs MOU with Woojung Bio
2023.05.18
Come and say hello to MEPSGEN at the BIO KOREA 2023
Come and say hello to MEPSGEN at the BIO KOREA 2023
2023.05.09
MEPSGEN, developing new medicines using human organs-on-chips technology
MEPSGEN, developing new medicines using human organs-on-chips technology
2023.02.13
YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'
YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'
2023.02.08
Online seminar : 'Microphysiological Barrier System for Drug Development'
Online seminar : 'Microphysiological Barrier System for Drug Development'
2023.02.06

Sitemap닫기

ABOUT
OVERVIEW
VISION
HISTORY
ORGANIZATION
OVERSEAS
CI
CONTACT
TECHNOLOGY
HUMAN ORGAN-ON-A-CHIP
BIOMIMETIC NANOPARTICLE
NANOPARTICLE MANUFACTURING
PIPELINE
MEPS-X
MG-X
SERVICE
SERVICE
NEWS
NOTICE
MEDIA
ARTICLE
CAREERS
CULTURE
HIRING PROCESS
WE'RE HIRING!